Clinical Trial Update: A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and tolerability of aducanumab in Alzheimer's disease patients who previously participated in Aducanumab studies 221AD103, 221AD…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aduhelm (aducanumab)

Snippet

Sponsor: Biogen | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-02-21